Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma

Clinical Trial ID NCT00901927

PubWeight™ 3.16‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00901927

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma. Clin Med Insights Oncol 2011 1.00
3 A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma. Curr Oncol 2012 0.81
Next 100